Cancer-Causing Proteins Winston Salem NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Susan Jean Hines, MD
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Cincinnati Coll Of Med, Cincinnati Oh 45267
Graduation Year: 1987

Data Provided by:
Ann Jones McCunniff
(336) 718-5095
3333 Silas Creek Pkwy
Winston Salem, NC
Specialty
Radiation Oncology

Data Provided by:
Susan Anitra Melin
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Hematology, Medical Oncology

Data Provided by:
Dr.Eugene Paschold
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Gender
M
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ
Year of Graduation: 1978
Speciality
Oncologist
General Information
Hospital: Wilkes Reg Med Ctr, N Wilkesboro, Nc
Accepting New Patients: Yes
RateMD Rating
3.5, out of 5 based on 4, reviews.

Data Provided by:
Thomas H Grote
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Christopher Reid Thomas
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Bayard Lowery Powell
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Medical Oncology

Data Provided by:
Yi-Kong Keung, MD
(336) 716-5847
Dept Of Internal Medicine
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Hong Kong, Fac Of Med, Hong Kong
Graduation Year: 1985

Data Provided by:
Ann Jones Mc Cunniff, MD
(336) 716-4981
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Med Coll Of Ga Sch Of Med, Augusta Ga 30912
Graduation Year: 1981

Data Provided by:
Arthur Edward Frankel, MD
(336) 716-3313
Med Center Dr Hanes 4046
Winston-Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1973

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com